Laurus Labs shares rose 3.5% on November 17 after Satyanarayana Chava, Founder and Chief Executive Officer, told CNBC-TV18 that he has no further plans for stake sale.
The pharma company stock fell 9% on November 16 after it emerged that sold Chava 14.85 lakh shares while V V Ravi Kumar, Executive Director & Chief Financial Officer, sold 4.78 lakh shares through Leven Holdings for Rs 500 crore.
In his personal capacity, Chava owns 0.29% stake (15.7 lakh shares) while Leven Holdings holds 1.15% stake (62.05 lakh shares). Also, NSN Holdings (represented by Chava) holds nearly 23% stake in the company (12.4 crore shares), showed shareholding data as of September.
On November 17, Chava told CNBC-TV18 that stake sale was done to pay off debt and philanthropy purposes.
At 12:20 pm on November 17, Laurus Labs stock was trading 3.6% higher at Rs 2,301.3 apiece.